Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1441-1450 of 2905 for cancer

Edit search filters
  1. Ibrutinib In Treating Minimal Residual Disease In Patients With Chronic Lymphocytic Leukemia After Front-Line Therapy

    Jacksonville, FL

  2. A Trial Of TTI-621 For Patients With Hematologic Malignancies And Selected Solid Tumors

    Jacksonville, FL, Rochester, MN

  3. A Study To Assess The Effectiveness And Safety Of Ublituximab In Combination With Umbralisib And Venetoclax (U2-V) Compared To Ublituximab And Umbralisib (U2) In Subjects With Chronic Lymphocytic Leukemia (CLL)

    Jacksonville, FL, Rochester, MN

  4. MR-Guided Cryoablation Of Prostate Bed Recurrences

    Rochester, MN

  5. A Study Of SAR442085 In Relapsed Or Refractory Multiple Myeloma

    Rochester, MN

  6. A Study To Evaluate Gleolan To Enhance Tumor Visualization In Patients With Newly-diagnosed Or Recurrent Meningioma

    Scottsdale/Phoenix, AZ, Rochester, MN

  7. Study To Assess The Effectiveness And Safety Of Ublituximab + TGR-1202 With Or Without Bendamustine And TGR-1202 Alone To Treat Patients With Previously Treated Non-Hodgkins Lymphoma

    Jacksonville, FL

  8. A Phase II, Multicenter Study Of The EZH2 Inhibitor Tazemetostat In Adult Subjects With INI1-Negative Tumors Or Relapsed/Refractory Synovial Sarcoma

    Jacksonville, FL

  9. A Study To Evaluate Treatment Of Established Chemotherapy-induced Neuropathy With Fingolimod

    Mankato, MN, Rochester, MN

  10. PH 1 Study To Evaluate Safety And Tolerability Of XmAb14045 In Patients With CD123-expressing Hematologic Malignancies

    Jacksonville, FL

.

Mayo Clinic Footer